Value-based neonatology (VBN): a new ethical paradigm for newborn care.

Abstract readReview

In one paragraph

Review in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Maria Luisa Di PietroCenter for Research and Studies On Procreative Health, University Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, L.Go F. Vito 1, 00168, Rome, Italy. marialuisa.dipietro@unicatt.it.ORCID https://orcid.org/0000-0002-3893-8788

Daniele De LucaDivision of Pediatric and Neonatal Critical Care, "A. Beclere" Medical Center, APHP-Paris Saclay University, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A few months ago, the Lancet Commission on the Future of Neonatology laid the foundations for boosting research and development in this field, ensuring modern, effective neonatal medicine. Worried about curing neonates as it was done 20 years ago, the Commission document provides a long list of actions for the various stakeholders. Several ethical issues arise in the background, which may go unnoticed, particularly by clinicians busy with routine clinical care. This review highlights some issues, explains the ethical reasoning behind the Lancet Commission document, and promotes the adoption of "Value-Based Neonatology". The value-based approach is already being used in other medical specialties, and we set out the framework for its application in neonatal medicine here.Conclusion: We believe that the full introduction of VBN in neonatal clinical care and research will help changing practicing, because it would be hopefully useful to optimise resource allocation and eventually decrease the areas of uncertainties.

Indexed as

NeonatologyHumansInfant, NewbornValue-Based Health CareDevelopmentNeonatal intensive care unitNeonateNewborn infantResearch

Identifiers

PMID42823491

DOI10.1007/s00431-026-07447-8

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.